Kineta, Inc Transitioning from Nasdaq to OTC Markets
Kineta will be trading under the symbol “KANT” on OTC Pink Kineta will continue to pursue strategic alternatives as previously announced TuHURA Biosciences has an exclusivity right and a right…
Producers Online
Kineta will be trading under the symbol “KANT” on OTC Pink Kineta will continue to pursue strategic alternatives as previously announced TuHURA Biosciences has an exclusivity right and a right…
Защо продължават да се увеличават служителите в изпълнителната власт? Според НСИ, по-бързо през последните месеци на временното ВРЕДИТЕЛСТВО (синоним на правителство, когато то не управлява, не прави и не допринася,…
27% ръст на неуточнения износ за ЕС. Та колко да е неуточнен този износ? За полугодието това е 1 875.7 милиона лева. Приложение 1 Близо 2 милиарда само за шест…
76% спад на чуждите инвестиции Януари – Юли спрямо същия период на миналата година. Приложение 1 Тогава чуждите „инвестиции“ са били 2 513.4 милиона евро, а тази година цели 604.3…
Communiqué de presse Lyon, le 20 septembre 2024 Dans le cadre de la restructuration financière d’UTI Group, EEKEM Group annonce son intention de déposer un projet d'offre publique d'achat simplifiée…
EMERYVILLE, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary gene editing toolbox,…
VANCOUVER, British Columbia, Sept. 19, 2024 (GLOBE NEWSWIRE) -- DMG Blockchain Solutions Inc. (TSX-V: DMGI) (OTCQB US: DMGGF) (FRANKFURT: 6AX) ("DMG"), a leading vertically integrated blockchain and data center technology…
WillScot Remains Focused on Executing $1 Billion of Idiosyncratic Growth Opportunities Board Increases Share Repurchase Authorization to $1 Billion PHOENIX, Sept. 18, 2024 (GLOBE NEWSWIRE) -- WillScot Holdings Corporation (“WillScot”…
Westford, USA, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Onychomycosis Market size was valued at USD 3.5 billion in 2023 to USD 5.05 billion by 2031, at a CAGR of 4.7%…
COPENHAGEN, Denmark, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced the pricing of its underwritten public offering of 2,000,000 American Depositary Shares (“ADSs”), each of…